Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
32.20    2.60 (8.78%)
Bid:
32.00
Ask:
32.20
Spread: 0.20 (0.625%)
Market Cap: £95.08m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Directorate Change - Replacement

3 Oct 2022 10:16

RNS Number : 5460B
Severfield PLC
03 October 2022
 

The following amendment has been made to the 'Directorate Change' announcement released on 3rd October 2022 at 7am under RNS No 3998B.

"The appointment forms part of Severfield's board succession process and it is intended that Mark should become Audit Chair following the retirement of Tony Osbaldiston in July 2023 at the end of his nine year tenure."

All other details remain unchanged.

The full amended text is shown below.

 

3 October 2022

Severfield plc

('the Company' or 'the Group')

Directorate Change

Appointment of Mark Pegler as Non-Executive Director

Severfield plc, the market leading structural steel group, is pleased to announce the appointment of Mark Pegler as a non-executive director with effect from 5 October 2022. He will serve on the Company's Remuneration, Nomination and Audit committees. The appointment forms part of Severfield's board succession process and it is intended that Mark should become Audit Chair following the retirement of Tony Osbaldiston in July 2023 at the end of his nine year tenure. 

Mark is an experienced FTSE 250 board director, having spent over a decade as Chief Financial Officer at Hill & Smith Holdings PLC. His successful tenure saw significant growth of the business, with organic growth supplemented by multiple bolt-on acquisitions and expansion of the Group internationally.

Mark is also a Non-Executive Director and Chair of the Audit Committee at ELE Advanced Technologies Ltd, a specialist in the production of complex and high integrity super alloy components for the aerospace, industrial gas turbine and commercial diesel engine markets. 

He is a Fellow of the Institute of Chartered Accountants in England and Wales (ICAEW).

Kevin Whiteman, Non-Executive Chairman, commented:

"We are pleased to welcome Mark to the Board of Severfield. He brings a wealth of relevant experience having spent a decade as CFO of a FTSE 250 business. His knowledge will be highly beneficial to Severfield as we continue to build on the considerable positive momentum within the business."

ENDS

For further information, please contact:

 

Severfield Alan Dunsmore 01845 577 896

Chief Executive Officer

 

Adam Semple 01845 577 896

Chief Financial Officer

 

Jefferies International Simon Hardy 020 7029 8000

Will Soutar 020 7029 8000

 

Liberum Capital Nicholas How 020 3100 2000

Ben Cryer 020 3100 2000

 

Camarco Ginny Pulbrook 020 3757 4980

Tom Huddart 020 3757 4980

 

 

 Notes to editors:

Severfield is the UK's market leader in the design, fabrication and construction of structural steel, with a total capacity of c.150,000 tonnes of steel per annum. The Group has six sites, c.1,500 employees and expertise in large, complex projects across a broad range of sectors. The Group also has an established presence in the expanding Indian market through its joint venture partnership with JSW Steel (India's largest steel producer).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGCBDGDBGDGDX
Date   Source Headline
16th Mar 202312:18 pmRNSProgressive publishes new research
15th Mar 20237:00 amRNSAcquisition
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.